COPART INC (CPRT) Insider Transactions
Explore official ownership filings, with every record linked to its source.
CPRT · COPART INC
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-10-15Filed 2026-10-19 | Morefield Diane MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.64 to $27.70, inclusive. The reporting person undertakes to provide to Copart, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 20,000D | 27.66 | Direct | Form 4 ↗0001193125-26-425293 |
| 2026-10-09Filed 2026-10-21 | JOHNSON WILLIS JDirector · Officer · Chairman of the BoardFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The shares were transferred by the Willis J. Johnson and Reba Johnson Revocable Trust to a separate trust for which the reporting person's wife serves as trustee. F2 The shares were transferred from the Willis J. Johnson and Reba Johnson Revocable Trust to the 2026 Willis Johnson Qualified Annuity Trust, for which the reporting person serves as trustee. References: F2 | J Other reported codeCommon Stock · Non-derivative | 3,090,000A | 0 | IndirectThe 2026 Willis J. Johnson Qualified Annuity Trust | Form 4 ↗0001193125-26-428030 |
| 2026-10-09Filed 2026-10-21 | JOHNSON WILLIS JDirector · Officer · Chairman of the BoardFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The shares were transferred by the Willis J. Johnson and Reba Johnson Revocable Trust to a separate trust for which the reporting person's wife serves as trustee. F2 The shares were transferred from the Willis J. Johnson and Reba Johnson Revocable Trust to the 2026 Willis Johnson Qualified Annuity Trust, for which the reporting person serves as trustee. References: F2 | J Other reported codeCommon Stock · Non-derivative | 3,090,000D | 0 | IndirectWillis J. Johnson and Reba Johnson Revocable Trust | Form 4 ↗0001193125-26-428030 |
| 2026-10-09Filed 2026-10-21 | JOHNSON WILLIS JDirector · Officer · Chairman of the BoardFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The shares were transferred by the Willis J. Johnson and Reba Johnson Revocable Trust to a separate trust for which the reporting person's wife serves as trustee. F2 The shares were transferred from the Willis J. Johnson and Reba Johnson Revocable Trust to the 2026 Willis Johnson Qualified Annuity Trust, for which the reporting person serves as trustee. References: F1 | J Other reported codeCommon Stock · Non-derivative | 3,090,000D | 0 | IndirectWillis J. Johnson and Reba Johnson Revocable Trust ReER | Form 4 ↗0001193125-26-428030 |
| 2026-08-16Filed 2026-08-18 | STEARNS LEAH COfficer · Chief Financial OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Copart, Inc. common stock. F2 Twenty percent of the Restricted Stock Units (RSUs) vest on the first anniversary of the grant date (August 16, 2027), and the balance vests cumulatively at a rate of 1/20 each three month quarter thereafter, such that 100% of the RSUs will vest on the fifth anniversary of the grant date. F3 100% of the stock options are subject to time -based vesting, with 20% of the stock options vesting on the first anniversary of the grant date, and the balance vesting at a rate of 1/60 per month thereafter, such that 100% of the stock options will vest and become exerciseable on the fifth anniversary of the grant date. In addition to the time-based vesting, 114,400 of the stock options are subject to an additional performance-based vesting condition and will not be exerciseable unless and until the trading price of the Copart, Inc. Common Stock in trading on the Nasdaq Global Select Market is an amount greater than or equal to $39.51 (125% of the per share exercise price) both (1) at the moment of any exercise, and (2) at the closing price for each of the twenty consecutive trading days preceding the date of any exercise. References: F3 | A Award / grantStock Options · Derivative | 200,000A | 0 | Direct | Form 4 ↗0001193125-26-355725 |
| 2026-08-16Filed 2026-08-18 | STEARNS LEAH COfficer · Chief Financial OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Copart, Inc. common stock. F2 Twenty percent of the Restricted Stock Units (RSUs) vest on the first anniversary of the grant date (August 16, 2027), and the balance vests cumulatively at a rate of 1/20 each three month quarter thereafter, such that 100% of the RSUs will vest on the fifth anniversary of the grant date. F3 100% of the stock options are subject to time -based vesting, with 20% of the stock options vesting on the first anniversary of the grant date, and the balance vesting at a rate of 1/60 per month thereafter, such that 100% of the stock options will vest and become exerciseable on the fifth anniversary of the grant date. In addition to the time-based vesting, 114,400 of the stock options are subject to an additional performance-based vesting condition and will not be exerciseable unless and until the trading price of the Copart, Inc. Common Stock in trading on the Nasdaq Global Select Market is an amount greater than or equal to $39.51 (125% of the per share exercise price) both (1) at the moment of any exercise, and (2) at the closing price for each of the twenty consecutive trading days preceding the date of any exercise. References: F1, F2 | A Award / grantRestricted Stock Units · Derivative | 12,654A | 0 | Direct | Form 4 ↗0001193125-26-355725 |
| 2026-08-16Filed 2026-08-18 | Pocock JaneOfficer · PresidentFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Copart, Inc. common stock. F2 Twenty percent of the Restricted Stock Units (RSUs) vest on the first anniversary of the grant date (August 16, 2027), and the balance vests cumulatively at a rate of 1/20 each three month quarter thereafter, such that 100% of the RSUs will vest on the fifth anniversary of the grant date. F3 100% of the stock options are subject to time -based vesting, with 20% of the stock options vesting on the first anniversary of the grant date, and the balance vesting at a rate of 1/60 per month thereafter, such that 100% of the stock options will vest and become exerciseable on the fifth anniversary of the grant date. In addition to the time-based vesting, 279,000 of the stock options are subject to an additional performance-based vesting condition and will not be exerciseable unless and until the trading price of the Copart, Inc. Common Stock in trading on the Nasdaq Global Select Market is an amount greater than or equal to $39.51 (125% of the per share exercise price) both (1) at the moment of any exercise, and (2) at the closing price for each of the twenty consecutive trading days preceding the date of any exercise. References: F3 | A Award / grantStock Options · Derivative | 500,000A | 0 | Direct | Form 4 ↗0001193125-26-355690 |
| 2026-08-16Filed 2026-08-18 | Pocock JaneOfficer · PresidentFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Copart, Inc. common stock. F2 Twenty percent of the Restricted Stock Units (RSUs) vest on the first anniversary of the grant date (August 16, 2027), and the balance vests cumulatively at a rate of 1/20 each three month quarter thereafter, such that 100% of the RSUs will vest on the fifth anniversary of the grant date. F3 100% of the stock options are subject to time -based vesting, with 20% of the stock options vesting on the first anniversary of the grant date, and the balance vesting at a rate of 1/60 per month thereafter, such that 100% of the stock options will vest and become exerciseable on the fifth anniversary of the grant date. In addition to the time-based vesting, 279,000 of the stock options are subject to an additional performance-based vesting condition and will not be exerciseable unless and until the trading price of the Copart, Inc. Common Stock in trading on the Nasdaq Global Select Market is an amount greater than or equal to $39.51 (125% of the per share exercise price) both (1) at the moment of any exercise, and (2) at the closing price for each of the twenty consecutive trading days preceding the date of any exercise. References: F1, F2 | A Award / grantRestricted Stock Units · Derivative | 25,308A | 0 | Direct | Form 4 ↗0001193125-26-355690 |
| 2026-08-13Filed 2026-08-17 | Berger David JoelDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Options vest on a monthly basis over the 12 months succeeding the grant date. F2 2007 Equity Incentive Plan. References: F1, F2 | A Award / grantStock Option · Derivative | 24,341A | 0 | Direct | Form 4 ↗0001193125-26-354472 |
| 2026-07-28Filed 2026-07-30 | Liaw JeffreyOfficer · Chief Executive OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The reported sale of 27,745 shares occurred automatically pursuan to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025. F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. F3 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. References: F3 | M Exercise / conversionStock Option · Derivative | 43,166D | 0 | Direct | Form 4 ↗0001193125-26-326503 |
| 2026-07-28Filed 2026-07-30 | Liaw JeffreyOfficer · Chief Executive OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The reported sale of 27,745 shares occurred automatically pursuan to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025. F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. F3 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. References: F2 | M Exercise / conversionStock Option · Derivative | 3,591D | 0 | Direct | Form 4 ↗0001193125-26-326503 |
| 2026-07-28Filed 2026-07-30 | Liaw JeffreyOfficer · Chief Executive OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The reported sale of 27,745 shares occurred automatically pursuan to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025. F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. F3 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 27,745D | 30.49 | Direct | Form 4 ↗0001193125-26-326503 |
| 2026-07-28Filed 2026-07-30 | Liaw JeffreyOfficer · Chief Executive OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The reported sale of 27,745 shares occurred automatically pursuan to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025. F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. F3 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. References: | M Exercise / conversionCommon Stock · Non-derivative | 43,166A | 8.7 | Direct | Form 4 ↗0001193125-26-326503 |
| 2026-07-28Filed 2026-07-30 | Liaw JeffreyOfficer · Chief Executive OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The reported sale of 27,745 shares occurred automatically pursuan to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025. F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. F3 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. References: | M Exercise / conversionCommon Stock · Non-derivative | 3,591A | 6.78 | Direct | Form 4 ↗0001193125-26-326503 |
| 2026-07-15Filed 2026-07-17 | Liaw JeffreyOfficer · Chief Executive OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. References: F2 | M Exercise / conversionStock Option · Derivative | 812D | 0 | Direct | Form 4 ↗0001193125-26-307951 |
| 2026-07-15Filed 2026-07-17 | Liaw JeffreyOfficer · Chief Executive OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. References: F1 | M Exercise / conversionStock Option · Derivative | 1,277D | 0 | Direct | Form 4 ↗0001193125-26-307951 |
| 2026-07-15Filed 2026-07-17 | Liaw JeffreyOfficer · Chief Executive OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. References: | M Exercise / conversionCommon Stock · Non-derivative | 812A | 8.7 | Direct | Form 4 ↗0001193125-26-307951 |
| 2026-07-15Filed 2026-07-17 | Liaw JeffreyOfficer · Chief Executive OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. F2 Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary. References: | M Exercise / conversionCommon Stock · Non-derivative | 1,277A | 6.78 | Direct | Form 4 ↗0001193125-26-307951 |
| 2026-07-13Filed 2026-07-15 | Englander Daniel JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.50 to $27.66, inclusive. The reporting person undertakes to provide to Copart, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. F2 Includes 275,352 shares held by Ursula Capital Partners, for which Mr. Englander serves as the sole general partner. F3 The reporting person is general partner of Ursula Capital Partners. On July 13, 2026, the reporting person caused Ursula Capital Partners to distribute 40,000 shares of Copart, Inc. common stock to its limited partners (excluding the reporting person). F4 Includes 235,352 shares owned by Ursula Capital Partners, for which Mr. Englander serves as the sole general partner. References: F3, F4 | J Other reported codeCommon Stock · Non-derivative | 40,000D | 0 | IndirectUrsual Capital Partners | Form 4 ↗0001193125-26-304271 |
| 2026-07-13Filed 2026-07-15 | Englander Daniel JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.50 to $27.66, inclusive. The reporting person undertakes to provide to Copart, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. F2 Includes 275,352 shares held by Ursula Capital Partners, for which Mr. Englander serves as the sole general partner. F3 The reporting person is general partner of Ursula Capital Partners. On July 13, 2026, the reporting person caused Ursula Capital Partners to distribute 40,000 shares of Copart, Inc. common stock to its limited partners (excluding the reporting person). F4 Includes 235,352 shares owned by Ursula Capital Partners, for which Mr. Englander serves as the sole general partner. References: F1, F2 | S Sale (market/private)Common Stock · Non-derivative | 80,000D | 27.55 | IndirectUrsula Capital Partners | Form 4 ↗0001193125-26-304271 |
| 2026-07-08Filed 2026-07-10 | Morefield Diane MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 2007 Equity Incentive Plan F2 Options vested on a monthly basis over the 12 months succeeding the grant date. References: F1, F2 | M Exercise / conversionStock Option · Derivative | 50,000D | 0 | Direct | Form 4 ↗0001193125-26-300603 |
| 2026-07-08Filed 2026-07-10 | Morefield Diane MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 2007 Equity Incentive Plan F2 Options vested on a monthly basis over the 12 months succeeding the grant date. References: | M Exercise / conversionCommon Stock · Non-derivative | 50,000A | 19.775 | Direct | Form 4 ↗0001193125-26-300603 |
| 2025-12-10Filed 2026-10-21 | JOHNSON WILLIS JDirector · Officer · Chairman of the BoardFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The shares were transferred by the Willis J. Johnson and Reba Johnson Revocable Trust to a separate trust for which the reporting person's wife serves as trustee. F2 The shares were transferred from the Willis J. Johnson and Reba Johnson Revocable Trust to the 2026 Willis Johnson Qualified Annuity Trust, for which the reporting person serves as trustee. References: | G GiftCommon Stock · Non-derivative | 129,200D | 0 | IndirectWillis and Reba's Foundation | Form 4 ↗0001193125-26-428030 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.